These Eli Lilly executives have been scooping up stock after its big drop
Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in…
Eli Lilly’s weight-loss pill disappointed in a key trial, but CEO David Ricks and other insiders together bought nearly $3 million worth of stock in…
The company beat revenue expectations on ‘unprecedented’ AI demand but posted a wider loss than analysts were predicting. View Source Christine Ji MarketWatch.com – Top…
History has shown that valuation metrics like price-to-earnings ratio aren’t all that useful when it comes to timing stock-market tops. View Source Joseph Adinolfi MarketWatch.com…
Shares of Cava Group Inc. tumbled late Tuesday after the Mediterranean fast-casual restaurant chain trimmed its full-year same-store sales outlook View Source Bill Peters MarketWatch.com…
Circle’s stock rose after the company’s first quarterly earnings update since its blockbuster IPO, as investors applauded the stablecoin issuer’s growth and plans for a…
David Solomon, the chair and chief executive of Goldman Sachs, is one of the biggest names on Wall Street. He’s now also the target of…
The service members had been told their early retirement had been approved, but then it was yanked away View Source Jessica Hall MarketWatch.com – Top…
The company says the sales came from indirect holdings and were for “tax and philanthropic purposes.” View Source Emily Bary MarketWatch.com – Top Stories August…
The good news is that you can buy lifetime income annuities whose payouts go up every year, and which are not at all dependent on…
The AI startup has reportedly put in a $34.5 billion bid to buy Chrome as a key antitrust ruling looms. But analysts say the price…